Cargando…

Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s

CCR5 is a member of the G-protein coupled receptor family that serves as an essential co-receptor for cellular entry of R5-tropic HIV-1, and is a validated target for therapeutics against HIV-1 infections. In the present study, we designed and synthesized a series of novel small CCR5 inhibitors and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakata, Hirotomo, Maeda, Kenji, Das, Debananda, Chang, Simon B., Matsuda, Kouki, Rao, Kalapala Venkateswara, Harada, Shigeyoshi, Yoshimura, Kazuhisa, Ghosh, Arun K., Mitsuya, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423129/ https://www.ncbi.nlm.nih.gov/pubmed/30886166 http://dx.doi.org/10.1038/s41598-019-41080-w

Ejemplares similares

GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro
por: Amano, Masayuki, et al.
Publicado: (2017)

GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
por: Hattori, Shin-ichiro, et al.
Publicado: (2020)

GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants
por: Aoki, Manabu, et al.
Publicado: (2023)

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates
por: Visseaux, Benoit, et al.
Publicado: (2015)

Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro
por: Hattori, Shin-ichiro, et al.
Publicado: (2018)

Driving HIV-1 into a Vulnerable Corner by Taking Advantage of Viral Adaptation and Evolution
por: Harada, Shigeyoshi, et al.
Publicado: (2017)

GrlR, a negative regulator in enteropathogenic E. coli, also represses the expression of LEE virulence genes independently of its interaction with its cognate partner GrlA
por: Lara-Ochoa, Cristina, et al.
Publicado: (2023)

A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC Activators
por: Matsuda, Kouki, et al.
Publicado: (2021)

Identification of a CCR5-Expressing T Cell Subset That Is Resistant to R5-Tropic HIV Infection
por: Oswald-Richter, Kyra, et al.
Publicado: (2007)

Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity
por: Bulut, Haydar, et al.
Publicado: (2020)

Growth potentials of CCR5-tropic/CXCR4-tropic HIV-1mt clones in macaque cells
por: Doi, Naoya, et al.
Publicado: (2013)

Screening of Anti-Adhesion Agents for Pathogenic Escherichia coli O157:H7 by Targeting the GrlA Activator
por: Hong, Sin Young, et al.
Publicado: (2023)

CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
por: Wu, Lijun, et al.
Publicado: (1997)

GrlJ, a Dictyostelium GABA(B)-like receptor with roles in post-aggregation development
por: Prabhu, Yogikala, et al.
Publicado: (2007)

Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity
por: Marti, Amelia, et al.
Publicado: (2006)

Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C–induced HIV latency reversal
por: Matsuda, Kouki, et al.
Publicado: (2019)

CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis
por: Joshi, Anjali, et al.
Publicado: (2017)

CCR5 Activation Promotes NLRP1-Dependent Neuronal Pyroptosis via CCR5/PKA/CREB Pathway After Intracerebral Hemorrhage
por: Yan, Jun, et al.
Publicado: (2021)

Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment
por: Lefebvre, E, et al.
Publicado: (2016)

Inhibition of Dual/Mixed Tropic HIV-1 Isolates by CCR5-Inhibitors in Primary Lymphocytes and Macrophages
por: Surdo, Matteo, et al.
Publicado: (2013)

CXCR4- and CCR5-Tropic HIV-1 Clones Are Both Tractable to Grow in Rhesus Macaques
por: Doi, Naoya, et al.
Publicado: (2018)

Host cell glycosylation selects for infection with CCR5- versus CXCR4-tropic HIV-1
por: Itell, Hannah L., et al.
Publicado: (2023)

CCR5 saves lives
por: Van Epps, Heather L.
Publicado: (2005)

The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations
por: Zare-Bidaki, Mohammad, et al.
Publicado: (2015)

The putative G protein–coupled receptor GrlD mediates extracellular polyphosphate sensing in Dictyostelium discoideum
por: Suess, Patrick M., et al.
Publicado: (2019)

Unique profile of predominant CCR5-tropic in CRF07_BC HIV-1 infections and discovery of an unusual CXCR4-tropic strain
por: Hu, Xiaoyan, et al.
Publicado: (2022)

CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab
por: Chang, Xiao L., et al.
Publicado: (2021)

CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells
por: Gao, Darrin, et al.
Publicado: (2016)

CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome
por: Kulkarni, Smita, et al.
Publicado: (2019)

The CCL5/CCR5 Axis in Cancer Progression
por: Aldinucci, Donatella, et al.
Publicado: (2020)

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines
por: Moody, M. Anthony, et al.
Publicado: (2010)

Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus
por: Ho, On, et al.
Publicado: (2009)

Pharmacokinetics, Safety and Efficacy of Maraviroc in Treatment-experienced Pediatric Patients Infected With CCR5-Tropic HIV-1
por: Giaquinto, Carlo, et al.
Publicado: (2018)

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection
por: Harms, Mirja, et al.
Publicado: (2023)

Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5
por: Zhang, Hui, et al.
Publicado: (2021)

Structure of GrlR and the Implication of Its EDED Motif in Mediating the Regulation of Type III Secretion System in EHEC
por: Jobichen, Chacko, et al.
Publicado: (2007)

Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor
por: Jiang, Xiaowei, et al.
Publicado: (2015)

The role of CCR5 in HCV infection
por: Coenen, Martin, et al.
Publicado: (2010)

Entanglement of CCR5 and Alzheimer’s Disease
por: Li, Tianwen, et al.
Publicado: (2019)

Expansion of Activated Memory CD4(+) T Cells Affects Infectivity of CCR5-Tropic HIV-1 in Humanized NOD/SCID/JAK3(null) Mice
por: Terahara, Kazutaka, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_507n6vrvhl96au3l76f5afe8g4